OCEA — Ocean Biomedical Balance Sheet
0.000.00%
Last trade - 00:00- $1.84m
- $11.19m
Annual balance sheet for Ocean Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.06 | 0.034 | 0.004 | 0 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.079 | 1.84 | 2.11 | 0.812 |
| Long Term Investments | ||||
| Total Assets | 0.079 | 1.84 | 5.5 | 0.902 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 6.74 | 12.7 | 30 | 33.9 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 6.74 | 12.7 | 96.3 | 98.5 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -6.66 | -10.8 | -90.8 | -97.6 |
| Total Liabilities & Shareholders' Equity | 0.079 | 1.84 | 5.5 | 0.902 |
| Total Common Shares Outstanding |